Our findings revealed a positive correlation between TMEM115 protein expression and CD68+ and CD68+CD163+ (M2 macrophages), which are associated with poor prognosis in many solid tumors (32), aligning with previous research across various solid tumors, thereby suggesting a consistent role of TMEM115 in tumor progression. The gene discussed is CD163; the disease is neoplasm.